These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18426893)

  • 1. Systemic expression of cytokine production in patients with severe pneumococcal pneumonia: effects of treatment with a beta-lactam versus a fluoroquinolone.
    Calbo E; Alsina M; Rodríguez-Carballeira M; Lite J; Garau J
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2395-402. PubMed ID: 18426893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of antibiotic therapy on systemic cytokine expression in pneumococcal pneumonia.
    Padrones S; Garcia-Vidal C; Fernández-Serrano S; Fernández A; Masuet C; Carratalà J; Coromines M; Ardanuy C; Gudiol F; Manresa F; Dorca J
    Eur J Clin Microbiol Infect Dis; 2010 Oct; 29(10):1243-51. PubMed ID: 20567869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.
    Frei CR; Jaso TC; Mortensen EM; Restrepo MI; Raut MK; Oramasionwu CU; Ruiz AD; Makos BR; Ruiz JL; Attridge RT; Mody SH; Fisher A; Schein JR
    Curr Med Res Opin; 2009 Apr; 25(4):859-68. PubMed ID: 19231913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of time on the systemic inflammatory response in pneumococcal pneumonia.
    Calbo E; Alsina M; Rodríguez-Carballeira M; Lite J; Garau J
    Eur Respir J; 2010 Mar; 35(3):614-8. PubMed ID: 19608588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Levofloxacin in the treatment of community-acquired pneumococcal pneumonia].
    Léophonte P; Veyssier P
    Presse Med; 1999 Nov; 28(36):1975-9. PubMed ID: 10599260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.
    Sørensen LK; Havemose-Poulsen A; Bendtzen K; Holmstrup P
    J Periodontol; 2009 Feb; 80(2):282-9. PubMed ID: 19186969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia.
    Frank E; Liu J; Kinasewitz G; Moran GJ; Oross MP; Olson WH; Reichl V; Freitag S; Bahal N; Wiesinger BA; Tennenberg A; Kahn JB
    Clin Ther; 2002 Aug; 24(8):1292-308. PubMed ID: 12240780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
    File TM; Segreti J; Dunbar L; Player R; Kohler R; Williams RR; Kojak C; Rubin A
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1965-72. PubMed ID: 9303395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia.
    Endimiani A; Brigante G; Bettaccini AA; Luzzaro F; Grossi P; Toniolo AQ
    BMC Infect Dis; 2005 Nov; 5():106. PubMed ID: 16307682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria.
    Gogos CA; Skoutelis A; Lekkou A; Drosou E; Starakis I; Marangos MN; Bassaris HP
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2793-8. PubMed ID: 15273083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe pneumococcal pneumonia: impact of new quinolones on prognosis.
    Olive D; Georges H; Devos P; Boussekey N; Chiche A; Meybeck A; Alfandari S; Leroy O
    BMC Infect Dis; 2011 Mar; 11():66. PubMed ID: 21406091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Failure of levofloxacin therapy in two cases of community-acquired pneumonia caused by fluoroquinolone-resistant Streptococcus pneumoniae and complicated with empyema].
    Carlavilla AB; López-Medrano F; Chaves F; Villena V; Echave-Sustaeta J; Aguado JM
    Enferm Infecc Microbiol Clin; 2005 May; 23(5):270-3. PubMed ID: 15899177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.
    Querol-Ribelles JM; Tenías JM; Querol-Borrás JM; Labrador T; Nieto A; González-Granda D; Martínez I
    Int J Antimicrob Agents; 2005 Jan; 25(1):75-83. PubMed ID: 15620830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ceftriaxone versus Levofloxacin for antibiotic therapy in patients with acute cholangitis].
    Kiesslich R; Will D; Hahn M; Nafe B; Genitsariotis R; Mäurer M; Jung M
    Z Gastroenterol; 2003 Jan; 41(1):5-10. PubMed ID: 12541165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levofloxacin treatment failure in a patient with fluoroquinolone-resistant Streptococcus pneumoniae pneumonia.
    Kays MB; Smith DW; Wack ME; Denys GA
    Pharmacotherapy; 2002 Mar; 22(3):395-9. PubMed ID: 11898897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity.
    Antunes G; Evans SA; Lordan JL; Frew AJ
    Eur Respir J; 2002 Oct; 20(4):990-5. PubMed ID: 12412694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levofloxacin Versus Ceftriaxone and Azithromycin Combination in the Treatment of Community Acquired Pneumonia in Hospitalized Patients.
    Izadi M; Dadsetan B; Najafi Z; Jafari S; Mazaheri E; Dadras O; Heidari H; SeyedAlinaghi S; Voltarelli F
    Recent Pat Antiinfect Drug Discov; 2018; 13(3):228-239. PubMed ID: 30360748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin failure in a patient with pneumococcal pneumonia.
    Empey PE; Jennings HR; Thornton AC; Rapp RP; Evans ME
    Ann Pharmacother; 2001 Jun; 35(6):687-90. PubMed ID: 11408985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory Effects of Levofloxacin on Patients with Pneumonia in Assiut University Hospitals.
    Badari MS; Elgendy SG; Mohamed AS; Hassan AT
    Egypt J Immunol; 2015; 22(1):79-85. PubMed ID: 26415375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.
    Bordon JM; Fernandez-Botran R; Wiemken TL; Peyrani P; Uriarte SM; Arnold FW; Rodriquez-Hernandez L; Rane MJ; Kelley RR; Binford LE; Uppatla S; Cavallazzi R; Blasi F; Aliberti S; Restrepo MI; Fazeli S; Mathur A; Rahmani M; Ayesu K; Ramirez J
    Infection; 2015 Dec; 43(6):729-38. PubMed ID: 26424683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.